SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BELLUS HEALTH INC.
(Exact name of registrant as specified in its charter)
|(State of incorporation or organization)||(IRS Employer Identification No.)|
275 Armand-Frappier Blvd.
Laval, Quebec, Canada
|(Address of principal executive offices)||(Zip Code)|
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class
to be so registered
Name of each exchange on which
each class is to be registered
|Common Shares||The NASDAQ Stock Market LLC|
If this Form 8-A relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is to become effective pursuant to General Instruction A.(c), please check the following box. x
If this Form 8-A relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is to become effective pursuant to General Instruction A.(d), please check the following box. ¨
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box ¨
Securities Act registration statement file number to which this form relates: 333-233592
Securities to be registered pursuant to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
|Item 1.||Description of Registrant’s Securities to be Registered.|
The securities to be registered consist of common shares, no par value (“Common Shares”) of BELLUS Health Inc. (the “Registrant”). The description of the Registrant’s Common Shares under the section captioned “Description of Share Capital – Common Shares” in the short form base shelf prospectus and under the sections captioned “Description of Capital Structure – Common Shares”, “Certain Canadian Federal Income Tax Considerations”, and “Material United States Federal Income Tax Considerations for U.S. Holders” in the prospectus supplement to the short form base shelf prospectus, each included in the Registrant’s registration statement on Form F-10 (File No. 333-233592) (the “Registration Statement”), initially filed with the Securities and Exchange Commission on September 3, 2019, as subsequently amended by any amendments to such Registration Statement, is incorporated herein by reference.
Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The NASDAQ Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Dated: September 3, 2019
|BELLUS HEALTH INC.|
|By:||/s/ Roberto Bellini|
|President and Chief Executive Officer|